JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma

Catalina Amador-Ortiz, Andres A. Roma, Phyllis C. Huettner, Nils Becker, John D. Pfeifer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Endometrial stromal sarcoma predominantly occurs as a primary tumor of the uterus. The most common cytogenetic abnormality in these tumors is t(7;17)(p15;q21), which occurs in 33% to 80% of cases and results in a JAZF1-JJAZ1 gene fusion. Rare cases of primary extrauterine endometrial stromal sarcoma have been reported, but it remains uncertain whether the genetic features of uterine endometrial stromal sarcoma are also characteristic of extrauterine tumors. The present study evaluates the prevalence of the t(7;17)(p15;q21) and JAZF1-JJAZ1 gene fusion in a series of 6 cases of primary extrauterine endometrial stromal sarcoma. Conventional nested reverse transcriptase-polymerase chain reaction was performed using primers complementary to sense and antisense JAZF1 and JJAZ1 sequences. Interphase fluorescence in situ hybridization was performed to detect t(7;17)(p15;q21) using a break-apart strategy for both JAZF1 and JJAZ1. In one of the 6 extrauterine endometrial stromal sarcoma cases, JAZF1-JJAZ1 fusion transcripts were detected by reverse transcriptase-polymerase chain reaction. The same case showed evidence of both JAZF1 and JJAZ1 rearrangements by interphase fluorescence in situ hybridization. The remaining 5 cases were negative for the t(7;17)(p15;q21) by both reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization analysis. These findings demonstrate that the t(7;17)(p15;q21) and associated JAZF1-JJAZ1 fusion transcripts are present in only a subset of primary extrauterine endometrial stromal sarcoma. Although molecular testing for the t(7;17)(p15;q21) and associated gene fusion may be useful for confirming primary extrauterine endometrial stromal sarcoma, the low prevalence of the genetic aberration limits the clinical utility of the testing.

Original languageEnglish (US)
Pages (from-to)939-946
Number of pages8
JournalHuman Pathology
Volume42
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Endometrial Stromal Sarcoma
Gene Fusion
Reverse Transcriptase Polymerase Chain Reaction
Fluorescence In Situ Hybridization
Interphase
Neoplasms
Chromosome Aberrations
Uterus
Cross-Sectional Studies

Keywords

  • Extrauterine endometrial stromal sarcoma
  • JAZF1-JJAZ1 gene fusion
  • t(7;17)(p15;q21)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma. / Amador-Ortiz, Catalina; Roma, Andres A.; Huettner, Phyllis C.; Becker, Nils; Pfeifer, John D.

In: Human Pathology, Vol. 42, No. 7, 01.07.2011, p. 939-946.

Research output: Contribution to journalArticle

Amador-Ortiz, Catalina ; Roma, Andres A. ; Huettner, Phyllis C. ; Becker, Nils ; Pfeifer, John D. / JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma. In: Human Pathology. 2011 ; Vol. 42, No. 7. pp. 939-946.
@article{a974454ffdd64fa8b5a3bcc14a9c9b06,
title = "JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma",
abstract = "Endometrial stromal sarcoma predominantly occurs as a primary tumor of the uterus. The most common cytogenetic abnormality in these tumors is t(7;17)(p15;q21), which occurs in 33{\%} to 80{\%} of cases and results in a JAZF1-JJAZ1 gene fusion. Rare cases of primary extrauterine endometrial stromal sarcoma have been reported, but it remains uncertain whether the genetic features of uterine endometrial stromal sarcoma are also characteristic of extrauterine tumors. The present study evaluates the prevalence of the t(7;17)(p15;q21) and JAZF1-JJAZ1 gene fusion in a series of 6 cases of primary extrauterine endometrial stromal sarcoma. Conventional nested reverse transcriptase-polymerase chain reaction was performed using primers complementary to sense and antisense JAZF1 and JJAZ1 sequences. Interphase fluorescence in situ hybridization was performed to detect t(7;17)(p15;q21) using a break-apart strategy for both JAZF1 and JJAZ1. In one of the 6 extrauterine endometrial stromal sarcoma cases, JAZF1-JJAZ1 fusion transcripts were detected by reverse transcriptase-polymerase chain reaction. The same case showed evidence of both JAZF1 and JJAZ1 rearrangements by interphase fluorescence in situ hybridization. The remaining 5 cases were negative for the t(7;17)(p15;q21) by both reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization analysis. These findings demonstrate that the t(7;17)(p15;q21) and associated JAZF1-JJAZ1 fusion transcripts are present in only a subset of primary extrauterine endometrial stromal sarcoma. Although molecular testing for the t(7;17)(p15;q21) and associated gene fusion may be useful for confirming primary extrauterine endometrial stromal sarcoma, the low prevalence of the genetic aberration limits the clinical utility of the testing.",
keywords = "Extrauterine endometrial stromal sarcoma, JAZF1-JJAZ1 gene fusion, t(7;17)(p15;q21)",
author = "Catalina Amador-Ortiz and Roma, {Andres A.} and Huettner, {Phyllis C.} and Nils Becker and Pfeifer, {John D.}",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.humpath.2010.11.001",
language = "English (US)",
volume = "42",
pages = "939--946",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma

AU - Amador-Ortiz, Catalina

AU - Roma, Andres A.

AU - Huettner, Phyllis C.

AU - Becker, Nils

AU - Pfeifer, John D.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Endometrial stromal sarcoma predominantly occurs as a primary tumor of the uterus. The most common cytogenetic abnormality in these tumors is t(7;17)(p15;q21), which occurs in 33% to 80% of cases and results in a JAZF1-JJAZ1 gene fusion. Rare cases of primary extrauterine endometrial stromal sarcoma have been reported, but it remains uncertain whether the genetic features of uterine endometrial stromal sarcoma are also characteristic of extrauterine tumors. The present study evaluates the prevalence of the t(7;17)(p15;q21) and JAZF1-JJAZ1 gene fusion in a series of 6 cases of primary extrauterine endometrial stromal sarcoma. Conventional nested reverse transcriptase-polymerase chain reaction was performed using primers complementary to sense and antisense JAZF1 and JJAZ1 sequences. Interphase fluorescence in situ hybridization was performed to detect t(7;17)(p15;q21) using a break-apart strategy for both JAZF1 and JJAZ1. In one of the 6 extrauterine endometrial stromal sarcoma cases, JAZF1-JJAZ1 fusion transcripts were detected by reverse transcriptase-polymerase chain reaction. The same case showed evidence of both JAZF1 and JJAZ1 rearrangements by interphase fluorescence in situ hybridization. The remaining 5 cases were negative for the t(7;17)(p15;q21) by both reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization analysis. These findings demonstrate that the t(7;17)(p15;q21) and associated JAZF1-JJAZ1 fusion transcripts are present in only a subset of primary extrauterine endometrial stromal sarcoma. Although molecular testing for the t(7;17)(p15;q21) and associated gene fusion may be useful for confirming primary extrauterine endometrial stromal sarcoma, the low prevalence of the genetic aberration limits the clinical utility of the testing.

AB - Endometrial stromal sarcoma predominantly occurs as a primary tumor of the uterus. The most common cytogenetic abnormality in these tumors is t(7;17)(p15;q21), which occurs in 33% to 80% of cases and results in a JAZF1-JJAZ1 gene fusion. Rare cases of primary extrauterine endometrial stromal sarcoma have been reported, but it remains uncertain whether the genetic features of uterine endometrial stromal sarcoma are also characteristic of extrauterine tumors. The present study evaluates the prevalence of the t(7;17)(p15;q21) and JAZF1-JJAZ1 gene fusion in a series of 6 cases of primary extrauterine endometrial stromal sarcoma. Conventional nested reverse transcriptase-polymerase chain reaction was performed using primers complementary to sense and antisense JAZF1 and JJAZ1 sequences. Interphase fluorescence in situ hybridization was performed to detect t(7;17)(p15;q21) using a break-apart strategy for both JAZF1 and JJAZ1. In one of the 6 extrauterine endometrial stromal sarcoma cases, JAZF1-JJAZ1 fusion transcripts were detected by reverse transcriptase-polymerase chain reaction. The same case showed evidence of both JAZF1 and JJAZ1 rearrangements by interphase fluorescence in situ hybridization. The remaining 5 cases were negative for the t(7;17)(p15;q21) by both reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization analysis. These findings demonstrate that the t(7;17)(p15;q21) and associated JAZF1-JJAZ1 fusion transcripts are present in only a subset of primary extrauterine endometrial stromal sarcoma. Although molecular testing for the t(7;17)(p15;q21) and associated gene fusion may be useful for confirming primary extrauterine endometrial stromal sarcoma, the low prevalence of the genetic aberration limits the clinical utility of the testing.

KW - Extrauterine endometrial stromal sarcoma

KW - JAZF1-JJAZ1 gene fusion

KW - t(7;17)(p15;q21)

UR - http://www.scopus.com/inward/record.url?scp=79959368206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959368206&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2010.11.001

DO - 10.1016/j.humpath.2010.11.001

M3 - Article

C2 - 21316079

AN - SCOPUS:79959368206

VL - 42

SP - 939

EP - 946

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 7

ER -